Tagged: Health Systems

Gibbons SFY 2026 Report: New Jersey Department of Health Presents Its FY 2026 Budget Proposal

This is the first in a series of posts that offers a detailed look into the budget proposals for the major departments that constitute the state government. On April 3, 2025, and April 7, 2025, New Jersey Department of Health (NJDOH) Commissioner Dr. Kaitlan Baston appeared before the Senate Budget and Appropriations Committee and the General Assembly Budget Committee, respectively, to testify and take questions on the NJDOH’s $1.4 billion proposed FY 2026 State budget. Backdrop of Federal Funding Cuts Last week, the Trump administration sought to cut over $11 billion in public health grants allocated to U.S. states during the COVID-19 pandemic. While the Trump administration’s efforts have been temporarily halted by a federal judge, the grant funding at risk is used by states to track, prevent, and control infectious diseases, including measles and bird flu. Commissioner Baston testified that nearly $300 million was cut from the Centers for Disease Control and Prevention, which was earmarked, in part, for local public health department funding. The Commissioner also highlighted that the funding supported direct care and disease and addiction prevention efforts. Investments in New Jersey’s Hospital and Health Care System The NJDOH’s Health Systems Branch oversees and ensures appropriate care in more than 2,000 regulated facilities statewide, including hospitals, nursing homes, and other healthcare facilities....

21st Century Cures Act Lands in Federal Budget Blueprint

President Trump’s proposed FY 2018 Budget (a/k/a the “skinny budget”) presented a departure from his predecessor’s proposed annual budgets – namely a $54 billion increase in defense and military spending paired with corresponding cuts to virtually every other federal department. But one area President Trump did not cut was the implementation of the 21st Century Cures Act (the “Cures Act”), which also happens to be one of the last bills signed into law by then-President Obama. The FY 2018 budget blueprint proposes to appropriate $1.1 billion towards the Cures Act’s implementation in the upcoming fiscal year. The Cures Act strives to expedite the discovery, development, and delivery of new treatments and cures. Those in the medical, biotechnology, and pharmaceutical industry should look to the Cures Act as the potential game-changer that the bipartisan sponsors of the law hoped it would be. Not only does the Cures Act provide the National Institute of Health with significant new funds to speed up research into diseases like cancer and Alzheimer’s, but it also attempts to speed up the process by which new treatments are reviewed and approved by the FDA. The Cures Act also focuses on changes to the treatment of mental health and substance abuse. The reforms included in the Cures Act create a new Assistant Secretary for...